Anika Therapeutics, Inc. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
Anika Therapeutics, Inc. (ANIK) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $56.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-10.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2016-03-10
- Anika Therapeutics, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2013 was $56.00K, a 46.10% increase from fiscal 2012.
- Anika Therapeutics, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2012 was $38.33K.
- Anika Therapeutics, Inc. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2010 was $37.81K.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month as first filed |
|---|---|---|
| 2013-12-31 | $56.00K 10-K · filed 2016-03-10 | $56.17K 10-K · filed 2014-03-13 |
| 2012-12-31 | $38.33K 10-K · filed 2015-03-13 | |
| 2010-12-31 | $37.81K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |